Carbonic anhydrase modulation of emotional memory. Implications for the treatment of cognitive disorders

References

• Tyng CM, Amin HU, Saad MNM, Malik AS. The influences of emotion on learning and memory. Front Psychol 2017;8:1454.
   PubMed Web of Science ®Google Scholar
• McGaugh JL. Consolidating memories. Annu Rev Psychol 2015;66:1–24.
   PubMed Web of Science ®Google Scholar
• Phelps EA, Sharot T. How (and Why) emotion enhances the subjective sense of recollection. Curr Dir Psychol Sci 2008;17:147–52.
   PubMed Web of Science ®Google Scholar
• Sharot T, Martorella EA, Delgado MR, Phelps EA. How personal experience modulates the neural circuitry of memories of September 11. Proc Natl Acad Sci USA 2007;104:389–94.
   PubMed Web of Science ®Google Scholar
• LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci 2000;23:155–84.
   PubMed Web of Science ®Google Scholar
• Visser RM, Lau-Zhu A, Henson RN, Holmes EA. Multiple memory systems, multiple time points: how science can inform treatment to control the expression of unwanted emotional memories. Philos Trans R Soc Lond B Biol Sci 2018;373.
   PubMed Web of Science ®Google Scholar
• Josselyn SA, Kohler S, Frankland PW. Finding the engram. Nat Rev Neurosci 2015;16:521–34.
   PubMed Web of Science ®Google Scholar
• Cahill L, McGaugh JL, Weinberger NM. The neurobiology of learning and memory: some reminders to remember. Trends Neurosci 2001;24:578–81.
   PubMed Web of Science ®Google Scholar
• (a) Izquierdo I, Furini CR, Myskiw JC. Fear Memory. Physiol Rev 2016;96:695–750.
   PubMed Web of Science ®Google Scholar
  (b) Provensi G, Costa A, Izquierdo I, et al. Brain histamine modulates recognition memory: possible implications in major cognitive disorders. Br J Pharmacol 2020;177:539–56.
   PubMed Web of Science ®Google Scholar
  (c) Provensi G, Passani MB, Costa A, et al. Neuronal histamine and the memory of emotionally salient events. Br J Pharmacol 2020;177:557–69.
   PubMed Web of Science ®Google Scholar
• (a) Phelps EA, Lempert KM, Sokol-Hessner P. Emotion and decision making: multiple modulatory neural circuits. Annu Rev Neurosci 2014;37:263–87.
   PubMed Web of Science ®Google Scholar
  (b) Benetti F, Furini CR, de Carvalho Myskiw J, et al. Histamine in the basolateral amygdala promotes inhibitory avoidance learning independently of hippocampus. Proc Natl Acad Sci USA 2015;112:E2536–42.
   PubMed Web of Science ®Google Scholar
• Tinsley MR, Quinn JJ, Fanselow MS. The role of muscarinic and nicotinic cholinergic neurotransmission in aversive conditioning: comparing pavlovian fear conditioning and inhibitory avoidance. Learn Mem 2004;11:35–42.
   PubMed Web of Science ®Google Scholar
• Pavlov PI. Conditioned reflexes: an investigation of the physiological activity of the cerebral cortex. Ann Neurosci 2010;17:136–41.
   PubMedGoogle Scholar
• Sweatt JD. Protooncogenes subserve memory formation in the adult CNS. Neuron 2001;31:671–4.
   PubMed Web of Science ®Google Scholar
• Sacchetti B, Lorenzini CA, Baldi E, et al. Auditory thalamus, dorsal hippocampus, basolateral amygdala, and perirhinal cortex role in the consolidation of conditioned freezing to context and to acoustic conditioned stimulus in the rat. J Neurosci 1999;19:9570–8.
   PubMed Web of Science ®Google Scholar
• McGaugh JL. Making lasting memories: remembering the significant. Proc Natl Acad Sci USA 2013;110:10402–7.
   PubMed Web of Science ®Google Scholar
• Maren S. Neurobiology of Pavlovian fear conditioning. Annu Rev Neurosci 2001;24:897–931.
   PubMed Web of Science ®Google Scholar
• Nesse RM. Evolutionary explanations of emotions. Hum Nat 1990;1:261–89.
   PubMedGoogle Scholar
• Myers KM, Davis M. Behavioral and neural analysis of extinction. Neuron 2002;36:567–84.
   PubMed Web of Science ®Google Scholar
• Myers KM, Davis M. Systems-level reconsolidation: reengagement of the hippocampus with memory reactivation. Neuron 2002;36:340–3.
   PubMed Web of Science ®Google Scholar
• Izquierdo I, McGaugh JL. Behavioural pharmacology and its contribution to the molecular basis of memory consolidation. Behav Pharmacol 2000;11:517–34.
   PubMed Web of Science ®Google Scholar
• Dolcos F, Katsumi Y, Weymar M, et al. Emerging Directions in Emotional Episodic Memory. Front Psychol 2017;8:1867.
   PubMed Web of Science ®Google Scholar
• Schmidt SD, Myskiw JC, Furini CR, et al. PACAP modulates the consolidation and extinction of the contextual fear conditioning through NMDA receptors. Neurobiol Learn Mem 2015;118:120–4.
   PubMed Web of Science ®Google Scholar
• Vetere G, Kenney JW, Tran LM, et al. Chemogenetic Interrogation of a Brain-wide Fear Memory Network in Mice. Neuron 2017;94:363–74 e364.
   PubMed Web of Science ®Google Scholar
• Milad MR, Quirk GJ. Fear extinction as a model for translational neuroscience: ten years of progress. Annu Rev Psychol 2012;63:129–51.
   PubMed Web of Science ®Google Scholar
• Sun MK, Alkon DL. Pharmacological enhancement of synaptic efficacy, spatial learning, and memory through carbonic anhydrase activation in rats. J Pharmacol Exp Ther 2001;297:961–7.
   PubMed Web of Science ®Google Scholar
• Pan PW, Parkkila AK, Autio S, et al. Brain phenotype of carbonic anhydrase IX-deficient mice. Transgenic Res 2012;21:163–76.
   PubMed Web of Science ®Google Scholar
• Canto de Souza L, Provensi G, Vullo D, et al. Carbonic anhydrase activation enhances object recognition memory in mice through phosphorylation of the extracellular signal-regulated kinase in the cortex and the hippocampus. Neuropharmacology 2017;118:148–56.
   PubMed Web of Science ®Google Scholar
• Yang MT, Chien WL, Lu DH, et al. Acetazolamide impairs fear memory consolidation in rodents. Neuropharmacology 2013;67:412–8.
   PubMed Web of Science ®Google Scholar
• De Simone G, Supuran CT. Antiobesity carbonic anhydrase inhibitors. Curr Top Med Chem 2007;7:879–84.
   PubMed Web of Science ®Google Scholar
• (a) Scozzafava A, Supuran CT, Carta F. Antiobesity carbonic anhydrase inhibitors: a literature and patent review. Expert Opin Ther Pat 2013;23:725–35.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases. Expert Opin Ther Pat 2018;28:713–21.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT. The management of glaucoma and macular degeneration. Expert Opin Ther Pat 2019;29:745–7.
   PubMed Web of Science ®Google Scholar
  (b) Fabrizi F, Mincione F, Somma T, et al. A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology. J Enzyme Inhib Med Chem 2012;27:138–47.
   PubMed Web of Science ®Google Scholar
• (a) Masini E, Carta F, Scozzafava A, Supuran CT. Antiglaucoma carbonic anhydrase inhibitors: a patent review. Expert Opin Ther Pat 2013;23:705–16.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT, Altamimi ASA, Carta F. Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019. Expert Opin Ther Pat 2019;29:781–92.
   PubMed Web of Science ®Google Scholar
• (a) Ozensoy Guler O, Supuran CT, Capasso C. Carbonic anhydrase IX as a novel candidate in liquid biopsy. J Enzyme Inhib Med Chem 2020;35:255–60.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT, Capasso C. Biomedical applications of prokaryotic carbonic anhydrases. Expert Opin Ther Pat 2018;28:745–54.
   PubMed Web of Science ®Google Scholar
  (c) Nocentini A, Supuran CT. Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. Expert Opin Drug Discov 2019;14:1175–97.
   PubMed Web of Science ®Google Scholar
• (a) Ozensoy Guler O, Capasso C, Supuran CT. A magnificent enzyme superfamily: carbonic anhydrases, their purification and characterization. J Enzyme Inhib Med Chem 2016;31:689–94.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Carbonic anhydrases and metabolism. Metabolites 2018;8:25.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT. Structure and function of carbonic anhydrases. Biochem J 2016;473:2023–32.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov 2017;12:61–88.
   PubMed Web of Science ®Google Scholar
  (c) Supuran CT. How many carbonic anhydrase inhibition mechanisms exist?. J Enzyme Inhib Med Chem 2016;31:345–60.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81.
   PubMed Web of Science ®Google Scholar
  (b) Alterio V, Di Fiore A, D’Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?. Chem Rev 2012;112:4421–68.
   PubMed Web of Science ®Google Scholar
  (c) De Simone G, Alterio V, Supuran CT. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert Opin Drug Discov 2013;8:793–810.
   PubMed Web of Science ®Google Scholar
• (a) Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767–77.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT, Capasso C. An Overview of the Bacterial Carbonic Anhydrases. Metabolites 2017;7:56.
   PubMed Web of Science ®Google Scholar
  (c) Capasso C, Supuran CT. An overview of the carbonic anhydrases from two pathogens of the oral cavity: streptococcus mutans and porphyromonas gingivalis. Curr Top Med Chem 2016;16:2359–68.
   PubMed Web of Science ®Google Scholar
  (d) Capasso C, Supuran CT. An Overview of the Selectivity and Efficiency of the Bacterial Carbonic Anhydrase Inhibitors. Curr Med Chem 2015;22:2130–9.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase activators. Future Med Chem 2018;10:561–73.
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria? J Enzyme Inhib Med Chem 2015;30:325–32.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Acetazolamide for the treatment of idiopathic intracranial hypertension. Expert Rev Neurother 2015;15:851–6.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibition and the management of neuropathic pain. Expert Rev Neurother 2016;16:961–8.
   PubMed Web of Science ®Google Scholar
• Thiry A, Dogne JM, Supuran CT, Masereel B. Carbonic anhydrase inhibitors as anticonvulsant agents. Curr Top Med Chem 2007;7:855–64.
   PubMed Web of Science ®Google Scholar
• Halmi P, Parkkila S, Honkaniemi J. Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus. Neurochem Int 2006;48:24–30.
   PubMed Web of Science ®Google Scholar
• (a) Capasso C, Supuran CT. Inhibition of bacterial carbonic anhydrases as a novel approach to escape drug resistance. Curr Top Med Chem 2017;17:1237–48.
   PubMed Web of Science ®Google Scholar
  (b) Capasso C, Supuran CT. Bacterial, fungal and protozoan carbonic anhydrases as drug targets. Expert Opin Ther Targets 2015;19:1689–704.
   PubMed Web of Science ®Google Scholar
• (a) De Simone G, Supuran CT. (In)organic anions as carbonic anhydrase inhibitors. J Inorg Biochem 2012;111:117–29.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?. J Enzyme Inhib Med Chem 2018;33:485–95.
   PubMed Web of Science ®Google Scholar
  (c) Tars K, Vullo D, Kazaks A, et al. Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases. J Med Chem 2013;56:293–300.
   PubMed Web of Science ®Google Scholar
• (a) Logozzi M, Capasso C, Di Raimo R, et al. Prostate cancer cells and exosomes in acidic condition show increased carbonic anhydrase IX expression and activity. J Enzyme Inhib Med Chem 2019;34:272–8.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. Expert Opin Investig Drugs 2018;27:963–70.
   PubMed Web of Science ®Google Scholar
  (c) Nocentini A, Supuran CT. Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018). Expert Opin Ther Pat 2018;28:729–40.
   PubMed Web of Science ®Google Scholar
• (a) Melis C, Distinto S, Bianco G, et al. Targeting tumor associated carbonic anhydrases IX and XII: highly isozyme selective coumarin and psoralen inhibitors. ACS Med Chem Lett 2018;9:725–9.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT, Alterio V, Di Fiore A, et al. Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one. Med Res Rev 2018;38:1799–836.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759–72.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery. Expert Opin Drug Discov 2020:1–16.; In press;
   PubMed Web of Science ®Google Scholar
  (c) Supuran CT. Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas. Expert Opin Ther Pat 2018;28:709–12.
   PubMed Web of Science ®Google Scholar
• (a) Lou Y, McDonald PC, Oloumi A, et al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 2011;71:3364–76.
   PubMed Web of Science ®Google Scholar
  (b) McDonald PC, Chia S, Bedard PL, et al. A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors. Am J Clin Oncol 2020. (in press)
   PubMed Web of Science ®Google Scholar
• (a) Maresca A, Temperini C, Vu H, et al. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009;131:3057–62.
   PubMed Web of Science ®Google Scholar
  (b) Maresca A, Temperini C, Pochet L, et al. Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem 2010;53:335–44.
   PubMed Web of Science ®Google Scholar
• D’Ambrosio K, Carradori S, Monti SM, et al. Out of the active site binding pocket for carbonic anhydrase inhibitors. Chem Commun (Camb) 2015;51:302–5.
   PubMed Web of Science ®Google Scholar
• (a) Briganti F, Mangani S, Orioli P, et al. Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine. Biochemistry 1997;36:10384–92.
   PubMed Web of Science ®Google Scholar
  (b) Temperini C, Scozzafava A, Vullo D, Supuran CT. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme. Chemistry 2006;12:7057–66.
   PubMed Web of Science ®Google Scholar
• (a) Temperini C, Scozzafava A, Supuran CT. Carbonic anhydrase activation and the drug design. Curr Pharm Des 2008;14:708–15.
   PubMed Web of Science ®Google Scholar
  (b) Temperini C, Innocenti A, Scozzafava A, et al. Carbonic anhydrase activators: L-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV. Bioorg Med Chem Lett 2007;17:628–35.
   PubMed Web of Science ®Google Scholar
• (a) Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 2000;41:S35–S39. Suppl
   PubMed Web of Science ®Google Scholar
  (b) Casini A, Antel J, Abbate F, et al. Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. Bioorg Med Chem Lett 2003;13:841–5.
   PubMed Web of Science ®Google Scholar
• Wang J, Ke T, Zhang X, et al. Effects of acetazolamide on cognitive performance during high-altitude exposure. Neurotoxicol Teratol 2013;35:28–33.
   PubMed Web of Science ®Google Scholar
• Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nat Neurosci 2010;13:1161–9.
   PubMed Web of Science ®Google Scholar
• Pattwell SS, Bath KG. Emotional learning, stress, and development: an ever-changing landscape shaped by early-life experience. Neurobiol Learn Mem 2017;143:36–48.
   PubMed Web of Science ®Google Scholar
• Naor C, Dudai Y. Transient impairment of cholinergic function in the rat insular cortex disrupts the encoding of taste in conditioned taste aversion. Behav Brain Res 1996;79:61–7.
   PubMed Web of Science ®Google Scholar
• McGaugh JL. Memory-a century of consolidation. Science 2000;287:248–51.
   PubMed Web of Science ®Google Scholar
• Gold PE, Hankins L, Edwards RM, et al. Memory interference and facilitation with posttrial amygdala stimulation: effect on memory varies with footshock level. Brain Res 1975;86:509–13.
   PubMed Web of Science ®Google Scholar
• Izquierdo I, Quillfeldt JA, Zanatta MS, et al. Sequential role of hippocampus and amygdala, entorhinal cortex and parietal cortex in formation and retrieval of memory for inhibitory avoidance in rats. Eur J Neurosci 1997;9:786–93.
   PubMed Web of Science ®Google Scholar
• LeDoux J. The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 2003;23:727–38.
   PubMed Web of Science ®Google Scholar
• McGaugh JL. Memory consolidation and the amygdala: a systems perspective. Trends Neurosci 2002;25:456.
   PubMed Web of Science ®Google Scholar
• Packard MG, Goodman J. Emotional arousal and multiple memory systems in the mammalian brain. Front Behav Neurosci 2012;6:14.
   PubMed Web of Science ®Google Scholar
• McIntyre CK, Miyashita T, Setlow B, et al. Memory-influencing intra-basolateral amygdala drug infusions modulate expression of Arc protein in the hippocampus. Proc Natl Acad Sci USA 2005;102:10718–23.
   PubMed Web of Science ®Google Scholar
• Packard MG, Cahill L, McGaugh JL. Amygdala modulation of hippocampal-dependent and caudate nucleus-dependent memory processes. Proc Natl Acad Sci USA 1994;91:8477–81.
   PubMed Web of Science ®Google Scholar
• Izquierdo I, Medina JH, Izquierdo LA, et al. Short- and long-term memory are differentially regulated by monoaminergic systems in the rat brain. Neurobiol Learn Mem 1998;69:219–24.
   PubMed Web of Science ®Google Scholar
• Hamann S. Cognitive and neural mechanisms of emotional memory. Trends Cogn Sci (Regul Ed) 2001;5:394–400.
   PubMed Web of Science ®Google Scholar
• LaLumiere RT, McGaugh JL, McIntyre CK. Emotional modulation of learning and memory: pharmacological implications. Pharmacol Rev 2017;69:236–55.
   PubMed Web of Science ®Google Scholar
• Sun MK, Zhao WQ, Nelson TJ, Alkon DL. Theta rhythm of hippocampal CA1 neuron activity: gating by GABAergic synaptic depolarization. J Neurophysiol 2001;85:269–79.
   PubMed Web of Science ®Google Scholar
• Sun MK, Dahl D, Alkon DL. Heterosynaptic transformation of GABAergic gating in the hippocampus and effects of carbonic anhydrase inhibition. J Pharmacol Exp Ther 2001;296:811–7.
   PubMed Web of Science ®Google Scholar
• Sun MK, Alkon DL. Carbonic anhydrase gating of attention: memory therapy and enhancement. Trends Pharmacol Sci 2002;23:83–9.
   PubMed Web of Science ®Google Scholar
• Davis S, Vanhoutte P, Pagès C, et al. The MAPK/ERK Cascade Targets Both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo. J Neurosci 2000;20:4563–72.
   PubMed Web of Science ®Google Scholar
• Waltereit R, Dammermann B, Wulff P, et al. Arg3.1/Arc mRNA Induction by Ca 2+ and cAMP Requires Protein Kinase A and Mitogen-Activated Protein Kinase/Extracellular Regulated Kinase Activation. J Neurosci 2001;21:5484–93.
   PubMed Web of Science ®Google Scholar
• Giovannini MG, Efoudebe M, Passani MB, et al. Improvement in fear memory by histamine-elicited ERK2 activation in hippocampal CA3 cells. J Neurosci 2003;23:9016–23.
   PubMed Web of Science ®Google Scholar